1. Pink Sheet

EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

 
• By Eliza Slawther

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.

The European Health Data Space will help EU companies be more innovative and agile (Shutterstock)
Key Takeaways
  • Orion Pharma explains which types of data it is most interested in accessing under the European Health Data Space Regulation once the legislation fully enters into force.

Orion Pharma, a Finnish-based company that operates globally, expects the new European Health Data Space (EHDS) to help it “move...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from Real-World Evidence